Skip to Main Content

Paper Details

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study.
BMJ
151
2021
SARS-CoV-2), anticoagulation, coronavirus 2, coronavirus disease, covid, covid-19, patients, severe acute respiratory syndrome coronavirus 2, thromboembolic events
Author NameAffiliation
Joshua A BeckmanVanderbilt University Medical Center and Vanderbilt Translational and Clinical Cardiovascular Research Center
Yuk-Lam HoVA Boston Healthcare System
Svetlana K EdenVanderbilt University School of Medicine
Robert A GreevyVanderbilt University Medical Center
Pei Jai Michael HoRocky Mountain Regional VA Medical Center, US Department of Veterans Affairs
Paul A HeidenreichVA Palo Alto Healthcare System, US Department of Veterans Affairs
Paul A HeidenreichStanford University School of Medicine
Amy C JusticeVA Connecticut Healthcare System, US Department of Veterans Affairs
Amy C JusticeYale School of Medicine
Amy C JusticeCenter for Interdisciplinary Research on AIDS, Yale School of Public Health
Matthew S FreibergVanderbilt University Medical Center
Matthew S FreibergGeriatric Research Education and Clinical Center, Tennessee Valley Healthcare System, US Department of Veterans Affairs
  • 1 - 12

Datasets

Release 1.2